Dr. Jonathan Robert Doty, DO

Dr. Doty practices at Michigan Institute for Neurological Disorders in Dearborn Heights, Michigan.

Dr. Doty's NPI, 1205495975, was assigned on June 6, 2019. Dr. Doty holds Michigan license 5101026941.

Dr. Doty's primary practice is Michigan Institute for Neurological Disorders, at 25150 Ford Rd, Dearborn Heights, MI 48127 in Wayne County. The practice phone is (248) 553-0010.

Dr. Doty's primary practice is Michigan Institute for Neurological Disorders in Dearborn Heights, Michigan. Dr. Doty is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Michigan Institute for Neurological Disorders. Dmand AI also links Dr. Doty to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doty practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Doty's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Doty is licensed in Michigan.

CMS data shows 404 Medicare services from Dr. Doty across 4 procedure codes in 2024, for 327 Medicare patients. Medicare paid $35,769 for them.

CMS counts 327 Medicare patients who saw Dr. Doty in 2024. The largest group is 75 to 84, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doty's median patient age at 58, with 64% women.

In 2024, Dr. Doty wrote 295 Medicare Part D claims for 113 patients. 85% of them were for generic drugs. CMS names the drug for 132 of them, across 8 drugs with 11 or more claims each, at $21,997 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Doty for performance year 2024, reported as part of a group. Dr. Doty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Doty as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Doty in 2023. 2023 was the busiest year, with 2. Dr. Doty's most frequent co-authors are Martin I. Belkin, DO and Smathorn Thakolwiboon, MD.

CMS Open Payments shows 103 general payments to Dr. Doty from 26 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 40% of the total. Sanofi and Genzyme US Companies paid the most, $16,723.